Cameron Durrant

(Dr. Cameron Durrant M.D.)

Currently holds a position at Humanigen Inc

Positions

Position Company Period
Chairman of the Board, Chief Executive Officer Humanigen Inc Sept. 5, 2017 -
Lead Independent Director Immune Pharmaceuticals Inc Jan. 21, 2015 - Sept. 10, 2018
Chairman of the Board, Chief Executive Officer, interim Chief Financial Officer Humanigen Inc Aug. 11, 2017 - Sept. 5, 2017
Chairman of the Board, Chief Executive Officer Humanigen Inc March 3, 2016 - Aug. 11, 2017
Independent Chairman of the Board Humanigen Inc Jan. 11, 2016 - March 3, 2016
Independent Director Immune Pharmaceuticals Inc July 10, 2014 - Jan. 21, 2015
President, Chief Executive Officer, Chief Financial Officer, Secretary, Treasurer, Director OncBioMune Pharmaceuticals Inc Oct. 31, 2012 - Aug. 7, 2013
President, Chief Executive Officer, Director OncBioMune Pharmaceuticals Inc Nov. 17, 2010 - Oct. 31, 2012
Cameron Durrant's trades of Humanigen Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2022-03-04 2022-03-02
US Humanigen Inc (HGEN)
B Purchase
40,000 +133.3%
2.34
USD 93,600 		40,000 +133.3% 2.34 USD 93,600
2021-06-16 2021-06-14
US Humanigen Inc (HGEN)
S Sale
49,906 -62.5%
20.61
USD 1,028,563 		49,906 -62.5% 20.61 USD 1,028,563
2021-06-16 2021-06-14
US Humanigen Inc (HGEN)
S Sale
5,094 -6.0%
21.14
USD 107,687 		5,094 -6.0% 21.14 USD 107,687
2021-06-16 2021-06-14
US Humanigen Inc (HGEN)
S Sale
26,441 -23.7%
20.60
USD 544,685 		26,441 -23.7% 20.60 USD 544,685
// ... existing code ... // ... rest of the file ...